Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Aviron deal

Aviron
Aviron entered into a CRADA with the National Institute of Allergy and Infectious Diseases and a licensing agreement with

Read the full 211 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE